Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction

Concurrent chemoradiation with carboplatin for locally advanced cervical cancer at high-risk for developing cisplatin-induced renal dysfunction

Bibliographic Details
Main Authors:	Dueñas-Gonzalez Alfonso, Hinojosa Jose, Rivera Lesbia, Guadarrama Roque, Mota Aida, Candelaria Myrna, Astorga Alma, Uribe Maria, Garcia-Arias Alicia, Cetina Lucely
Format:	Article
Language:	English
Published:	BMC 2007-02-01
Series:	BMC Cancer

Similar Items

Chemoradiation with cisplatin followed by either brachytherapy or radical hysterectomy. A non-randomized comparison in FIGO stages IB2-IIA
by: Cantu David, et al.
Published: (2007-02-01)

Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients
by: Flores Vladimir, et al.
Published: (2009-02-01)

Chemoradiation with Cisplatin vs. Carboplatin for Squamous Cell Carcinoma of the Head and Neck (SCCHN)
by: Dirk Rades, et al.
Published: (2023-06-01)

Comparison of neoadjuvant chemoradiation with carboplatin/ paclitaxel or cisplatin/ 5-fluoruracil in patients with squamous cell carcinoma of the esophagus
by: Stefan Münch, et al.
Published: (2017-11-01)

Cisplatin-induced ototoxicity in patients receiving concurrent chemoradiation in carcinoma cervix
by: Hanan M, et al.
Published: (2022-07-01)

Concurrent Chemoradiation With Weekly Gemcitabine and Cisplatin in Locally Advanced Cervical Cancer
by: Esmati E, et al.
Published: (2011-12-01)

Comparison of definite chemoradiation therapy with carboplatin/paclitaxel or cisplatin/5-fluoruracil in patients with squamous cell carcinoma of the esophagus
by: Stefan Münch, et al.
Published: (2018-08-01)

Cisplatin Induced SIADH in Patients Receiving Concurrent Chemoradiation Therapy: A Rare Clinical Observation
by: Chevireddy Praneetha, et al.
Published: (2018-11-01)

A prospective comparative study of concurrent chemoradiation in advanced carcinoma cervix patients with weekly cisplatin vs. weekly cisplatin and paclitaxel
by: Amit K Mukherjee, et al.
Published: (2022-01-01)

Hypersensitivity and cross-reactivity to cisplatin and carboplatin
by: Gholamreza Faridaalaee, et al.
Published: (2016-07-01)

Concurrent chemoradiation for vaginal cancer.
by: David T Miyamoto, et al.
Published: (2013-01-01)

Epigenetics of cervical cancer. An overview and therapeutic perspectives
by: Cetina Lucely, et al.
Published: (2005-10-01)

Radiation-sparing managements for cervical cancer: a developing countries perspective
by: de la Garza Jaime, et al.
Published: (2006-11-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
by: Imtiaz Ahmed, et al.
Published: (2021-05-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Syeda Uzma Naqvi, et al.
Published: (2016-08-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Syeda Uzma Naqvi, et al.
Published: (2016-08-01)

Efficiency of Cisplatin Based Concurrent Chemoradiation in Stages III & IV Head & Neck Squamous Cell Carcinoma
by: Kulsoom Begum, et al.
Published: (2016-08-01)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
by: Muhammad Shahid Iqbal, et al.
Published: (2017-04-01)

Post hoc analysis of a randomized controlled trial comparing concurrent chemoradiation with cisplatin versus nimotuzumab-cisplatin, focusing on acute oral mucositis
by: Vanita Noronha, et al.
Published: (2021-05-01)

"CONCURRENT CHEMORADIATION FOR ESOPHAGEAL CARCINOMA: PRELIMINARY RESULTS"
by: MM. Merati SM. Sajjadi, et al.
Published: (2004-08-01)

"CONCURRENT CHEMORADIATION FOR ESOPHAGEAL CARCINOMA: PRELIMINARY RESULTS"
by: P. Haddad, et al.
Published: (2004-06-01)

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
by: Muhammad Furqan, et al.
Published: (2019-06-01)

Incidence and risk factors for acute kidney injury in head and neck cancer patients treated with concurrent chemoradiation with high-dose cisplatin
by: Maurice J. D. L. van der Vorst, et al.
Published: (2019-11-01)

HER2 expression in cervical cancer as a potential therapeutic target
by: Vidal Silvia, et al.
Published: (2004-09-01)

Conventional chemoradiation with Cisplatin Versus hemoradiation with Cisplatin plus Gemcitabine in uterine cervical cancer
by: Ahmad Ameri (MD), et al.
Published: (2008-10-01)

Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer
by: I Ya Bazaeva, et al.
Published: (2015-09-01)

Efficacy of intensity-modulated radiotherapy with concurrent carboplatin in nasopharyngeal carcinoma
by: Songthong Anussara, et al.
Published: (2015-06-01)

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
by: Eric S Kim, et al.
Published: (2017-01-01)

A prospective randomized study to compare weekly versus tri-weekly cisplatin-based concurrent chemoradiation in the treatment of locally advanced carcinoma cervix
by: Arshad Mollah, et al.
Published: (2022-06-01)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
by: Feiya Shi, et al.
Published: (2022-03-01)

First Results of Concurrent Chemoradiation with Two Courses of 5 × 25 mg/m<sup>2</sup> Cisplatin for Locally Advanced Head and Neck Cancer
by: Inga Zwaan, et al.
Published: (2023-06-01)

A Single-Arm Phase 2 Trial on Induction Chemotherapy Followed by Concurrent Chemoradiation in Nasopharyngeal Carcinoma Using a Reduced Cumulative Dose of Cisplatin
by: Zhiyuan Xu, et al.
Published: (2022-04-01)

Correlation Between Higher Cumulative Dose of Cisplatin for Concurrent Chemoradiation and Acute Kidney Disease Incidence Among Nasopharyngeal Carcinoma Patients: A Comparative Study
by: Rachman A, et al.
Published: (2021-12-01)

Correction: Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer.
by: PLOS Staff
Published: (2018-01-01)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
by: Ding Q, et al.
Published: (2013-08-01)

Role of concurrent chemoradiation on locally advanced unresectable adenoid cystic carcinoma
by: Hyerim Ha, et al.
Published: (2021-01-01)

A Potentially Less Nephrotoxicity of Carboplatin Over Cisplatin as Radiosensitizer in Head-neck Cancer
by: Mahfujul Ahmed Riad
Published: (2022-08-01)

Safety and Efficacy of Weekly Paclitaxel and Cisplatin Chemotherapy for Ovarian Cancer Patients with Hypersensitivity to Carboplatin
by: Shinichi Tate, et al.
Published: (2021-02-01)

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)

Cisplatin or carboplatin in the treatment of non-small cell lung cancer: a comprehensive review
by: Marcello Tiseo, et al.
Published: (2011-12-01)